Amit Lahav, MD
Orthopaedic Surgery · Orange, CTNPI 1518054113
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,550 of the $34,055 with a category attached, or 75.0%. Conformis, Inc. accounts for 89.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $20,875 and has fallen 99.4% since, to $125 in 2025.
Across 107 payments — averaging $318.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$31K
- Medacta USA, Inc.$835
- Pacira Therapeutics, Inc.$536
- AstraZeneca$357
- Johnson & Johnson$326
- Vericel Corporation$250
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$25,55075%
- Travel & lodging$4,12612%
- Food & beverage$4,37913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 35 | $30,598 |
| Medacta USA, Inc. | 6 | $835 |
| Pacira Therapeutics, Inc. | 19 | $536 |
| AstraZeneca | 3 | $357 |
| Johnson & Johnson | 7 | $326 |
| Vericel Corporation | 2 | $250 |
| Amgen | 24 | $233 |
| Medtronic(2 entities) | 2 | $222 |
| Zimmer Biomet | 1 | $133 |
| Novo Nordisk | 1 | $125 |
| Boehringer Ingelheim | 1 | $122 |
| Stryker | 3 | $110 |
| Merck | 1 | $102 |
| Medical Device Business Services, Inc. | 1 | $91 |
| Assertio Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTotal CR$19,151
- Identity CR$3,499
- Identity$2,975
- Hip Stem III$2,625
- Hip$1,249
- GMK Sphere Revision System$578
- iTotal CR, iTotal PS, iUni, Hip System$452
- MACI$250
- Zilretta$248
- Persona Revision$133
- AIRSUPRA$125
- Ozempic$125
- FARXIGA$121
- Reveal LINQ$114
- BREZTRI$111
- KYPHON Balloon Kyphoplasty$108
- STEGLATRO$102
How this compares
$34,055 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $5,970 |
| Celecoxib | 194 | $2,678 |
| Oxycodone Hcl | 143 | $884 |
| Dexamethasone | 105 | $712 |
| Ondansetron Hcl | 139 | $409 |
| Clobetasol Propionate | 19 | $374 |
| Cephalexin | 31 | $253 |
| Mupirocin | 27 | $234 |
| Amoxicillin | 111 | $210 |
| Gabapentin | 53 | $188 |
| Meloxicam | 90 | $180 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $123 |
| Tramadol Hcl | 18 | $83 |
| Hydromorphone Hcl | 12 | $83 |
| Clindamycin Hcl | 22 | $70 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Orange
- Peter WhangNew Haven$1.8M
- Paul SethiGreenwich$1.5M
- James YueShelton$1.3M
- Robert DeveneyDanbury$907K
- James PaceFarmington$721K
- Isaac MossFarmington$676K
- David FrumbergNew Haven$288K
- John KeggiMiddlebury$264K
- Lauren GeaneyFarmington$263K
- Robert StantonFairfield$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.